No consensus: Clinical trials wrestle with role of atropine in treating amblyopia


Baltimore-Amblyopia is a relatively common problem in children, but there is no consensus on the best treatment. Recently, there has been increasing interest in using atropine drops instead of patching, but they are not FDA approved for that indication, said Michael X. Repka, MD.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.